Welcome to LookChem.com Sign In|Join Free
  • or
tert-butyl [(2R,3S)-2-(aminomethyl)-1-(2,4-dimethoxybenzyl)-4-oxoazetidin-3-yl]carbamate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1380110-38-2

Post Buying Request

1380110-38-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1380110-38-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1380110-38-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,0,1,1 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1380110-38:
(9*1)+(8*3)+(7*8)+(6*0)+(5*1)+(4*1)+(3*0)+(2*3)+(1*8)=112
112 % 10 = 2
So 1380110-38-2 is a valid CAS Registry Number.

1380110-38-2Relevant academic research and scientific papers

Process Development for the Synthesis of Monocyclic β-Lactam Core 17

Lall, Manjinder S.,Tao, Yong,Arcari, Joel T.,Boyles, David C.,Brown, Matthew F.,Damon, David B.,Lilley, Susan C.,Mitton-Fry, Mark J.,Starr, Jeremy,Stewart, Andrew Morgan,Sun, Jianmin

, p. 212 - 218 (2018)

Process development and multikilogram synthesis of the monocyclic β-lactam core 17 for a novel pyridone-conjugated monobactam antibiotic is described. Starting with commercially available 2-(2,2-diethoxyethyl)isoindoline-1,3-dione, the five-step synthesis features several telescoped operations and direct isolations to provide significant improvement in throughput and reduced solvent usage over initial scale-up campaigns. A particular highlight in this effort includes the development of an efficient Staudinger ketene-imine [2 + 2] cycloaddition reaction of N-Boc-glycine ketene 12 and imine 9 to form racemic β-lactam 13 in good isolated yield (66%) and purity (97%). Another key feature in the synthesis involves a classical resolution of racemic amine 15 to afford single enantiomer salt 17 in excellent isolated yield (45%) with high enantiomeric excess (98%).

MONOBACTAMS

-

Page/Page column 85-86, (2012/06/16)

The present invention is directed to a new class of monobactam derivatives and their use for treating bacterial infections.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1380110-38-2